| |
| |
|
| Insider
Information: |
Dunn John Michael |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
36,637 |
|
|
Indirect Shares
|
160 |
|
|
| Direct
Value |
$5,348,675 |
|
|
|
Indirect Value
|
$34,480 |
|
|
| Total
Shares |
36,797 |
|
|
| Total
Value |
$5,383,155 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -17.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
EVP, New Ventures |
2009-02-24 |
24,752 |
2005-12-22 |
160 |
Premium* |
|
|
Immunic Inc |
IMUX |
General Counsel and Se... |
2017-06-14 |
11,885 |
2015-10-23 |
0 |
Premium* |
|
|
Acer Therapeutics Inc |
ACER |
Director |
2023-11-17 |
0 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACER |
Acer Therapeutics Inc |
Director |
– • – |
2023-11-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(27,380) |
0 |
0 |
- |
|
| ACER |
Acer Therapeutics Inc |
Director |
– • – |
2020-07-24 |
4 |
B |
$3.50 |
$74,998 |
D/D |
21,428 |
27,380 |
2.39 |
% |
|
| ACER |
Acer Therapeutics Inc |
|
• • – |
2017-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,952 |
5,952 |
0 |
- |
|
| IMUX |
Immunic Inc |
General Counsel and Secretary |
• – – |
2017-06-14 |
4 |
B |
$3.08 |
$7,724 |
D/D |
2,500 |
11,885 |
2.74 |
- |
|
| IMUX |
Immunic Inc |
General Counsel and Secretary |
• – – |
2015-10-26 |
4 |
B |
$7.00 |
$14,000 |
D/D |
2,000 |
9,385 |
2.74 |
- |
|
| IMUX |
Immunic Inc |
General Counsel and Secretary |
• – – |
2015-10-23 |
4 |
B |
$6.76 |
$49,933 |
D/D |
7,385 |
7,385 |
2.74 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2009-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
6,040 |
24,752 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2009-02-19 |
4 |
AS |
$50.90 |
$163,301 |
D/D |
(3,208) |
18,712 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2009-02-12 |
4 |
D |
$52.61 |
$159,724 |
D/D |
(3,036) |
21,920 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2009-02-11 |
4 |
AS |
$50.81 |
$114,729 |
D/D |
(2,258) |
24,956 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2009-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,633 |
28,589 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2009-02-06 |
4 |
D |
$52.48 |
$72,160 |
D/D |
(1,375) |
27,214 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-07-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
32 |
24,956 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-07-22 |
4 |
AS |
$71.50 |
$463,678 |
D/D |
(6,485) |
24,988 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-07-22 |
4 |
OE |
$43.50 |
$282,098 |
D/D |
6,485 |
31,473 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-07-21 |
4 |
AS |
$67.50 |
$437,738 |
D/D |
(6,485) |
24,988 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-07-21 |
4 |
OE |
$4,350.00 |
$28,209,750 |
D/D |
6,485 |
31,473 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-06-02 |
4 |
OE |
$35.37 |
$55,106 |
D/D |
1,558 |
24,962 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-04-14 |
4 |
AS |
$64.06 |
$206,196 |
D/D |
(3,212) |
23,404 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-03-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
45 |
26,178 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-02-12 |
4/A |
A |
$0.00 |
$0 |
D/D |
10,430 |
28,490 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-02-12 |
4/A |
AS |
$60.46 |
$138,202 |
D/D |
(2,267) |
26,223 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-02-12 |
4 |
D |
$60.56 |
$108,281 |
D/D |
(1,788) |
18,060 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-02-12 |
4 |
AS |
$60.46 |
$138,202 |
D/D |
(2,267) |
15,793 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, New Ventures |
• – – |
2008-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,430 |
26,223 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
